Item 2.02 Results of Operations and Financial Condition
On November 2, 2009, Valeant Pharmaceuticals International issued a press release announcing results of operations for the quarter ended September 30, 2009 and certain other financial information as of and for the quarter ended September 30, 2009. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. Item 9.01 Financial Statements and Exhibits.
(d) Exhibits

99.1 Press release dated November 2, 2009.

---

Table of Contents